Compare ENLV & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENLV | SITC |
|---|---|---|
| Founded | 2005 | 1965 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 153.8M |
| IPO Year | 2014 | 1994 |
| Metric | ENLV | SITC |
|---|---|---|
| Price | $0.81 | $2.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $20.00 | $8.00 |
| AVG Volume (30 Days) | 281.6K | ★ 842.2K |
| Earning Date | 05-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 123.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $123,649,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.43 | $2.80 |
| 52 Week High | $7.64 | $9.08 |
| Indicator | ENLV | SITC |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 38.97 |
| Support Level | $0.72 | $2.89 |
| Resistance Level | $0.94 | $3.11 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 19.59 | 52.27 |
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing, and managing shopping centers.